Floatz logo

Her-2 Vaccine

GIST

Robert WesolowskivaccinePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the GIST cohort.

Asset / SponsorPhaseRating
MIDAZOLAM
Blueprint Medicines Corporation
Phase 4BBB
Regorafenib
Institut Bergonié
Phase 4BBB
Esomeprazole
Erasmus Medical Center
Phase 4BB
CAFFEINE
Markus Joerger
Phase 4BB
Imatinib
M.D. Anderson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

Her-2 Vaccine is also rated in:

cancerDormant
CC
Indicative ·
47 / 100
View asset →
colon carcinomaDormant
CC
Indicative ·
47 / 100
View asset →
breast cancerDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →